Large Cell Lung Carcinoma
📧 Sign up to get email alerts when something new happens for Large Cell Lung Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial evaluates stereotactic body radiation therapy with or without nivolumab for patients with Stage I-IIA or recurre…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [NA]
This clinical trial update outlines a study of image-guided hypofractionated radiation therapy with a stereotactic body radiation therapy bo…
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC [Phase 2]
Phase 2 trial evaluating nivolumab combined with radiotherapy in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating cisplatin and etoposide with or without veliparib in extensive-stage small cell lung cancer has completed recru…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel, carboplatin, and bevacizumab with or without Cixutumumab in stage IV or recurrent non-small cell lung c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation [Phase 4]
A Phase 4 trial evaluating everolimus (RAD001) in combination with paclitaxel and carboplatin as first-line therapy for advanced large cell …
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer [Phase 3]
Pfizer-sponsored Phase 3 trial evaluating figitumumab (CP-751,871) with erlotinib in refractory lung cancer was terminated and results were …